Home    Back

Lutein (10 or 30 mg/day) capsules    (DrugBank: Lutein)

2 diseases
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1
164Oculocutaneous albinism0

90. Retinitis pigmentosa    [ 103 clinical trials,   158 drugs,   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways]
Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 103 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00029289
(ClinicalTrials.gov)		April 20019/1/2002Effects of Lutein in Retinitis PigmentosaEffects of Lutein in Retinitis PigmentosaRetinitis PigmentosaDrug: Lutein (10 or 30 mg/day) capsulesNational Center for Complementary and Integrative Health (NCCIH)NULLCompletedPhase 1;Phase 2United States

164. Oculocutaneous albinism    [ 15 clinical trials,   57 drugs,   (DrugBank: 34 drugs),   34 drug target genes,   136 drug target pathways]
Searched query = "Oculocutaneous albinism", "Hermansky-Pudlak syndrome", "Chediak-Higashi syndrome", "Griscelli syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 15 trial found